Correlation Between Verona Pharma and Carmell Therapeutics
Can any of the company-specific risk be diversified away by investing in both Verona Pharma and Carmell Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verona Pharma and Carmell Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verona Pharma PLC and Carmell Therapeutics, you can compare the effects of market volatilities on Verona Pharma and Carmell Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verona Pharma with a short position of Carmell Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verona Pharma and Carmell Therapeutics.
Diversification Opportunities for Verona Pharma and Carmell Therapeutics
-0.69 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Verona and Carmell is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Verona Pharma PLC and Carmell Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Carmell Therapeutics and Verona Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verona Pharma PLC are associated (or correlated) with Carmell Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Carmell Therapeutics has no effect on the direction of Verona Pharma i.e., Verona Pharma and Carmell Therapeutics go up and down completely randomly.
Pair Corralation between Verona Pharma and Carmell Therapeutics
Given the investment horizon of 90 days Verona Pharma PLC is expected to generate 0.45 times more return on investment than Carmell Therapeutics. However, Verona Pharma PLC is 2.22 times less risky than Carmell Therapeutics. It trades about 0.22 of its potential returns per unit of risk. Carmell Therapeutics is currently generating about -0.09 per unit of risk. If you would invest 3,419 in Verona Pharma PLC on August 31, 2024 and sell it today you would earn a total of 571.00 from holding Verona Pharma PLC or generate 16.7% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Verona Pharma PLC vs. Carmell Therapeutics
Performance |
Timeline |
Verona Pharma PLC |
Carmell Therapeutics |
Verona Pharma and Carmell Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Verona Pharma and Carmell Therapeutics
The main advantage of trading using opposite Verona Pharma and Carmell Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verona Pharma position performs unexpectedly, Carmell Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Carmell Therapeutics will offset losses from the drop in Carmell Therapeutics' long position.Verona Pharma vs. Cue Biopharma | Verona Pharma vs. Eliem Therapeutics | Verona Pharma vs. Inhibrx | Verona Pharma vs. Molecular Partners AG |
Carmell Therapeutics vs. ZyVersa Therapeutics | Carmell Therapeutics vs. Sonnet Biotherapeutics Holdings | Carmell Therapeutics vs. Revelation Biosciences | Carmell Therapeutics vs. Quoin Pharmaceuticals Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Fundamental Analysis View fundamental data based on most recent published financial statements |